Why Standard Vision Screening Falls Short for Children With Neurodevelopmental Disorders
As of 2022 CDC data, approximately 1 in 31 U.S. children has autism spectrum disorder (ASD), and up to 71% of those children experience some form of visual challenge. Among children with cerebral palsy, the numbers are even more striking: vision problems affect 75% to 90%, including reduced acuity, visual field defects, and oculomotor dysfunction.
Standard ophthalmic tools frequently fail this population. Research shows that intraocular pressure testing was completable in only 37.5% of nonverbal children and 44.4% of children with ASD. These are not minor inconveniences; they represent fundamental testability failures.
The 2025 NCCVEH (National Center for Children's Vision and Eye Health) updated preschool vision screening guidelines formally classify ASD, cerebral palsy, Down syndrome, and developmental delay as high-risk conditions. These children require adapted protocols, not standard pass/fail screening. The guidelines recommend direct referral to an optometrist or ophthalmologist rather than reliance on school-based screening alone.
The clinical stakes are significant. Undetected vision problems compound developmental and learning challenges in children already navigating complex neurodevelopmental conditions. Early, accurate identification changes outcomes.
Selecting the Right Optotypes: LEA SYMBOLS® and HOTV for Non-Verbal and Pre-Literate Patients
The 2025 NCCVEH guidelines are clear: LEA SYMBOLS® and HOTV are the only optotypes recommended for pre-literate and non-verbal pediatric vision screening. Both systems use a matching response format. Children point to or touch a corresponding card rather than verbally naming a symbol, removing the communication barrier entirely.
A 2024 JAAPOS systematic review and meta-analysis covering 7,948 patients confirmed that LEA SYMBOLS® and HOTV are clinically comparable for visual acuity measurement. However, LEA SYMBOLS® demonstrated statistically higher testability among children aged 3 to 5 (p=0.047). For the youngest and most cognitively limited patients, this makes LEA SYMBOLS® the preferred first-line tool.
Matching response cards also offer a practical advantage for children with motor limitations. Minnesota Department of Health protocols recommend reproducing and spacing out LEA SYMBOLS® or HOTV response cards so children with limited fine motor control, such as those with cerebral palsy, can make larger physical matching movements. This is a low-cost modification with high clinical impact.
Snellen and letter-based charts are inappropriate for this population. Clinicians should not attempt to adapt letter charts as a substitute. They were not designed for non-verbal or pre-literate patients, and using them introduces unnecessary measurement error.
Good-Lite is the exclusive distributor of the LEA® Test System, which has become the clinical standard for pediatric populations where communication and cognition present barriers to traditional testing.
Instrument-Based Screening: When Optotype Testing Is Not Possible
For nonverbal children and those with ASD, the American Academy of Ophthalmology's Pediatric Eye Evaluation Preferred Practice Pattern recommends automated, instrument-based screening as the primary approach. Photoscreeners and handheld autorefractors (such as the Spot Vision Screener) detect refractive errors without requiring verbal responses or sustained cooperation from the child.
A 2025 cross-sectional study of 210 children with ASD (mean age 8.18 years; 83.3% male) demonstrated the feasibility of this approach in a real-world setting. Conducted in an autism education center, the study used exclusively non-contact methods: the LANG I stereotest, cover-uncover and Hirschberg tests, Spot Vision Screener, and Brückner test. Results identified refractive errors in 22.3% of participants and strabismus in 11.9%, most commonly intermittent exotropia.
Retinoscopy (objective refraction) deserves particular emphasis. This technique provides a full refractive assessment with zero verbal demand from the patient. For nonverbal children with ASD or developmental delays, retinoscopy is an essential component of any adapted examination protocol.
A practical decision sequence for clinicians:
- Attempt instrument-based screening first (photoscreener or handheld autorefractor).
- If tolerated, layer in optotype matching using LEA SYMBOLS® or HOTV.
- If testing cannot be completed, document the result as "untestable" with a clear clinical rationale.
An "untestable" result is clinically meaningful. It justifies immediate referral to a pediatric ophthalmologist or optometrist and functions as a referral trigger, not a documentation gap to overlook.
Cerebral Palsy and CVI: Why a Completely Different Testing Approach Is Required
Cerebral/cortical visual impairment (CVI) is now the leading cause of pediatric visual impairment in developed countries. A 2022 Danish registry study found that CVI accounted for 36% of visually impaired children. Among children with cerebral palsy, 75% to 90% have co-occurring vision problems, and half have comorbid developmental disabilities. Complexity is the norm in this population, not the exception.
A critical clinical distinction must be made: ocular vision problems (refractive error, strabismus) and brain-based vision problems (CVI) require entirely different testing approaches and equipment. Standard optotype charts cannot assess CVI. They measure ocular function, not the brain's ability to interpret visual information.
The CVI Range, developed by Christine Roman-Lantzy, is the specialized functional vision assessment protocol for children with suspected CVI. It encompasses caregiver interviews, naturalistic observation, and face-to-face evaluation. No optotype charts are involved. A 2025 scoping review confirmed that CVI diagnostic protocols include medical history, parent reports, visual field testing, optic nerve and oculomotor examinations, and visual perceptual assessments. This multi-modal approach reflects the complexity of brain-based visual impairment.
On the emerging frontier, AI-based visual saliency testing (in development at USC Children's Hospital Los Angeles as of 2025) signals a future direction for CVI assessment in non-communicative children. While not yet widely available, this technology may eventually offer objective, scalable CVI evaluation.
When standard testing is untestable and CVI is suspected, clinicians must document that suspicion clearly in referral notes. This documentation ensures the child reaches appropriate specialized care.
Stereoacuity Testing and Other Adapted Protocols for ASD and Developmental Delays
The 2025 NCCVEH guidelines mandate annual stereopsis screening for children aged 3 to under 6. Children with ASD and neurodevelopmental delays require specifically adapted stereo testing protocols to meet this standard.
The LANG I stereotest, used successfully in the 2025 ASD screening study of 210 children, is a non-contact, non-verbal stereoacuity method requiring only a gaze response from the child. This makes it particularly well-suited for children who cannot or will not speak during an exam.
Strabismus prevalence in children with ASD ranges from 11.9% to over 15%, compared to approximately 4% in typical pediatric populations. Cover-uncover and Hirschberg tests are feasible non-verbal alternatives for strabismus assessment and should be part of every adapted screening protocol.
A 2025 U.S. National Survey of Children's Health analysis revealed an important gender disparity: females with ASD have 2.3 times higher odds of co-morbid vision problems than males (OR: 2.3, p<0.001). Clinicians should not underscreen girls based on lower ASD prevalence assumptions. The same analysis found developmental delay was the most common neuropsychiatric co-morbidity in children with ASD at 64%, meaning screening protocols must account for compounded cognitive and motor limitations.
The recommended testing sequence: prioritize non-contact, non-verbal tests first. Layer in optotype matching only if tolerated. Always document what was attempted, what was completed, and what was deferred.
Creating a Sensory-Friendly Exam Environment
Environmental modifications are not optional extras for children with ASD. Evidence supports specific accommodations: dimmed lighting, reduced ambient noise, shorter verbal instructions, and removal of unnecessary stimuli from the exam room. Each of these reduces sensory overload and improves cooperation.
Pre-visit tours of the clinic help reduce anxiety and improve exam completion rates. This is a low-cost protocol modification that can be implemented immediately. Extended appointment slots are also clinically necessary for this population. Standard 15-minute slots are insufficient for the multi-modal, adapted protocols these children require.
Collaboration with educators and caregivers makes a measurable difference. The 2025 ASD screening study, conducted in an autism education center rather than a clinical office, demonstrated that meeting children in familiar settings with trusted adults improves both access and testability.
Caregiver-reported visual behavior observations are a valid clinical data source. Incorporating structured parent or caregiver questionnaires into the pre-exam workflow gives clinicians actionable information before the child enters the exam room.
Sensory-friendly clinic design is becoming a clinical differentiator. With ASD prevalence at 1 in 31 children, practices that offer these accommodations are better positioned to serve a growing patient population and provide more complete care.
Clinical Takeaways: Building an Adapted Vision Screening Protocol
Building an effective adapted screening protocol starts with diagnosis-specific tool selection:
- ASD: Lead with instrument-based screening (photoscreener, handheld autorefractor) and retinoscopy. Add optotype matching with LEA SYMBOLS® if tolerated.
- Cerebral palsy: Conduct functional vision assessment and refer for CVI Range evaluation when brain-based visual impairment is suspected.
- Developmental delay: Use LEA SYMBOLS® matching with motor adaptations (spaced response cards per Minnesota DOH protocols).
The 2025 NCCVEH guidelines have codified neurodevelopmental disorders as high-risk categories. Compliance now requires documented adapted protocols, not workarounds.
"Untestable" is a referral trigger. Document every method attempted, every result obtained, and every test deferred. This documentation protects both the clinician and the child.
Multidisciplinary collaboration is essential. Vision therapists, educators, caregivers, and pediatric specialists all contribute to a complete clinical picture. No single provider can address these children's needs in isolation.
Good-Lite's LEA® Test System, backed by nearly a century of industry expertise since 1930, provides the evidence-based equipment foundation for building these protocols. As the exclusive distributor of the LEA® Test System, Good-Lite offers the full range of pediatric vision screening tools designed for pre-literate, non-verbal, and special needs populations. Explore our complete catalog of adapted pediatric screening tools to equip your practice for every patient you serve.
